EP 0741572 A1 19961113 - AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL

Title (en)

AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL

Title (de)

MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIEN-3,17-g(b)-DIOL

Title (fr)

SUBSTANCE POUR APPLICATION TRANSDERMIQUE CONTENANT DU 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL

Publication

EP 0741572 A1 19961113 (DE)

Application

EP 94905711 A 19940127

Priority

EP 9400213 W 19940127

Abstract (en)

[origin: WO9520392A1] Described is an agent, intended for transdermal administration, which is characterized in that it contains 14 alpha ,17 alpha -ethanoestra-1,3,5(10)-triene-3,17 beta -diol, optionally in combination with one or two gestagens.

IPC 1-7

A61K 31/565; A61K 9/70

IPC 8 full level

A61K 47/28 (2006.01); A61K 9/70 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01)

CPC (source: EP)

A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 9/7084 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01)

C-Set (source: EP)

Citation (search report)

See references of WO 9520392A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9520392 A1 19950803; AU 5971294 A 19950815; EP 0741572 A1 19961113; FI 962993 A0 19960726; FI 962993 A 19960726; JP H09510697 A 19971028; NO 963128 D0 19960726; NO 963128 L 19960726

DOCDB simple family (application)

EP 9400213 W 19940127; AU 5971294 A 19940127; EP 94905711 A 19940127; FI 962993 A 19960726; JP 51984495 A 19940127; NO 963128 A 19960726